Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α. (Q54333652)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 September 2014

Language	Label	Description	Also known as
English	Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α.	scientific article published on 24 September 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25082025

Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25082025

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25082025

Hans K. Hasselbalch

4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25082025

Inge Marie Svane

7

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25082025

Per thor Straten

6

object named as

Per Thor Straten

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

author name string

Caroline H Riley

1

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25082025

Marie K Brimnes

3

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25082025

Ole W Bjerrum

5

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25082025

Morten Krogh Jensen

8

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25082025

publication date

24 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25082025

European Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25082025

94

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25082025

3

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25082025

227-234

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25082025

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

The myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

A gain-of-function mutation of JAK2 in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2a

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Sustained major molecular response on interferon alpha-2b in two patients with polycythemia vera.

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

The renaissance of interferon therapy for the treatment of myeloid malignancies

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Interferon-alpha in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms. Status and perspectives

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Complete molecular remission in a polycythaemia vera patient 12 years after discontinuation of interferon-alpha.

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Interferons, immunity and cancer immunoediting

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use.

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Direct effects of type I interferons on cells of the immune system

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Human natural killer cells

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

The biology of human natural killer-cell subsets

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16 NK cells as rapid producers of abundant IFN-gamma on activation

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

CD56bright natural killer (NK) cells: an important NK cell subset.

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Unique subpopulations of CD56 NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Natural-killer cells and dendritic cells: "l'union fait la force".

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

NK cell and DC interactions

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

IFN-α primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity.

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Interleukin-12 and the regulation of innate resistance and adaptive immunity

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Natural killer cells in innate immunity and cancer

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

DC-NK cell cross talk as a novel CD4 T-cell-independent pathway for antitumor CTL induction

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

NK cells provide helper signal for CD8 T cells by inducing the expression of membrane-bound IL-15 on DCs.

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

IL-18-induced CD83 CCR7 NK helper cells

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remission

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera

1 reference

https://api.crossref.org/works/10.1111/EJH.12420

21 January 2018

Identifiers

10.1111/EJH.12420

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25082025

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25082025

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54333652&oldid=2071869489"